Effect of Carbamazepine on the Serum Level of Thyrotropin-Releasing Hormone

Authors

  • Ume Kalsoom Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University Peshawar, Pakistan
  • Niaz Ali Department of Pharmacology, Institute of Basic Medical Sciences, Khyber Medical University Peshawar, Pakistan

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20192201

Keywords:

Carbamazepine, FT4, T3, Thyroid gland, Thyrotropin-Releasing Hormone, TSH

Abstract

Background: The thyroid gland is endocrine gland located in front and lower side of neck. Thyroid gland secretes two types of thyroid hormones that are triiodothyronine (T3) and tetraiodothyronine (T4). The hypothalamus is a center for regulation of thyroid hormones. It senses the low hormone levels and in turn releases thyrotropin-releasing hormone (TRH). TRH stimulates anterior pituitary to release TSH which then acts on the thyroid gland to maintain normal level of T3 and T4. The objective of study is to determine the effects of carbamazepine on TRH in euthyroid rabbits.

Methods: An experimental study performed on 30 rabbits. These were divided into three groups having 10 rabbits in each group. 10 rabbits were treated with 10mg/kg/day of CBZ (OD), other 10 with 35mg/kg/day CBZ (three divided doses) and 10 rabbits served as control. T3, FT4, TSH and TRH levels were evaluated at baseline and after 21 days of treatment in all three groups by Electro-chemiluminescence immunoassay and ELISA respectively.

Results: Comparison of the hormone levels of the control group and the group having a dose of 10 mg/kg/day for 21 day of treatment. Comparative results showed serum level of T3 (P=0.031), FT4 (P=0.030), and TRH (P=0.044) levels significantly lower than the control group and TSH (P=0.057) levels remain unaltered. It was also found that group having a dose of 35 mg/kg/day; TDS showed decrease in T3 (P value 0.001), FT4 (P=0.001), TSH (P=0.003) and TRH (P=0.001) level as compared to control group.

Conclusions: Our data suggest that Carbamazepine monotherapy does alter thyroid hormones and its central regulatory hormone TRH. Decrease in TRH level increase level of depression and suicidal thoughts and also risk of tertiary hypothyroidism. These findings could have very important clinical implications.

Metrics

Metrics Loading ...

References

Zoeller RT, Tan SW, Tyl RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol. 2007 Jan-Feb;37(1-2):11-53.

Ciloglu F, Peker I, Pehlivan A, Karacabey K, Ilhan N, Saygin O, et al. Exercise intensity and its effects on thyroid hormones. Neuro Endocrinol Lett. 2005 Dec;26(6):830-4.

Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995 Mar 8;273(10):808-12.

Hussain Z, Elahi S. Undetected hypothyroidism and its anesthetic implications. Anaesth Pain Intensive Care. 2012;16(2):205-10.

Desai J, Yassa L, Marqusee E, George S, Frates MC, Chen MH, et al. Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med. 2006 Nov 7;145(9):660-4.

Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011 Jun;21(6):593-646.

Pack, A. Effects of treatment on endocrine function in patients with epilepsy. Current treatment options in neurol. 2005;7(4):273-280.

Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D. Enzyme induction with antiepileptic drugs: cause for concern? Epilepsia. 2013;54(1):11-27.

Tolou-Ghamari Z, Zare M, Habibabadi JM, Najafi MR. A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J Res Med Sci. 2013;18(Suppl 1):S81-S85.

Okuma T, Kishimoto A. A history of investigation on the mood stabilizing effect of carbamazepine in Japan. Psychiatry clin neurosci. 1998;52(1):3-12.

Löfgren E, Tapanainen JS, Koivunen R, Pakarinen A, Isojärvi JI. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia. 2006;47(9):1441-6.

Leśkiewicz M, Budziszewska B, Lasoń W. Endocrine effects of antiepileptic drugs. Przegl Lek. 2007;65(11):795-8.

Bongu D, Sachdev J, Kabadi UM. Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis. Endocr Pract.1999;5(5):239-244.

Scott A, Waldman AT. Pharmacology and Therapeutics Principal to practice. Elsevier Inc.1st Ed. 2008:1378.

Connell JM, Rapeport WG, Gordon S, Brodie MJ. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine. European J Clin Pharmacol. 1984;26(4):453-6.

Kaur RJ, Mehta B, Ambwani SR, Gehlot A. Effect of calcium channel blockers on the serum levels of thyroid hormone. Int J Basic Clin Pharmacol. 2013;2(4):476-9.

Verrotti A, Basciani F, Morresi S, Morgese G, Chiarelli F. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol. 2001;25(1):43-6.

Isojärvi JI, Airaksinen KE, Repo M, Pakarinen AJ, Salmela P, Myllylä VV. Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients. J Neurol Neurosur Psychiatry. 1993;56(6):710-2.

Amirsalari S, Dost ZT, Kavemanesh Z, Torkaman M, Beiraghdar F, Afsharpayman S, et al. Thyroid function in epileptic children who receive carbamazepine, primidone, phenobarbital and valproic acid. Iranian Journal of Child Neurology. 2011;5(2):17-22.

Kirimi E, Karasalihoğlu S, Boz A. Thyroid functions in children under long-term administration of antiepileptic drugs. Eastern J Med. 1999;4(1):23-6.

Simko J, Horacek J. Carbamazepine and risk of hypothyroidism: a prospective study. Acta Neurol Scand. 2007 Nov;116(5):317-21.

Verrotti A, Laus M, Scardapane A, Franzoni E, Chiarelli F. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. European J Endocrinol. 2009 Jan 1;160(1):81-6.

Aggarwal A, Rastogi N, Mittal H, Chillar N, Patil R. Thyroid hormone levels in children receiving carbamazepine or valproate. Pediatr Neurol. 2011 Sep 1;45(3):159-62.

Aanderud S, Myking OL, Strandjord RE. The influence of carbamazepine on thyroid hormones and thyroxine binding globulin in hypothyroid patients substituted with thyroxine. Clin Endocrinol. 1981 Sep;15(3):247-52.

Melmed S. The Pituitary. 3rd Ed. USA:Elsevier Inc;2011.729.

Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Therapeut. 2001 Apr 1;90(1):21-34.

Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9(1):68-82.

Ambrósio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res. 2002 Feb;27(1-2):121-30.

Evans GA, David DN, Rosenfeld MG. Regulation of prolactin and somatotropin mRNAs by thyroliberin. Proceedings of the National Academy of Sciences. 1978 Mar 1;75(3):1294-8.

Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag. 2007 Oct;3(5):929-51.

Karapanou O, Papadimitriou A. Thyroid hormone transporters in the human. Hormones. 2011 Oct 1;10(4):270-9.

hiamolera MI, Wondisford FE. Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinol. 2009 Mar;150(3):1091-6.

Baumgartner A, Pinna G, Hiedra L, Gaio U, Hessenius C, Campos-Barros A, et al. Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology. 1997 Jan;16(1):25-41.

Mitsuma T, Hirooka Y, Yuasa K, Nogimori T. Effects of thyroid hormone, TRH and TSH on pro-TRH concentrations in various organs of rats. Endocrinol Exp. 1990 Dec;24(4):395-402.

Santos-Silva AP, Andrade MN, Pereira-Rodrigues P, Paiva-Melo FD, Soares P, Graceli JB, et al. Frontiers in endocrine disruption: Impacts of organotin on the hypothalamus-pituitary-thyroid axis. Mol Cell Endocrinol. 2018 Jan 15;460:246-57.

Chakera AJ, Pearce SH, Vaidya B. Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther. 2012;6:1-11.

Gupta V, Lee M. Central hypothyroidism. Indian J Endocrinol Metabolism. 2011 Jul;15(Suppl2):S99.

Hypothalamic-Pituitary-Thyroid Axis | Maitland Chiropractor - The Bolick Clinic of Chiropractic Wellness | Maitland Chiropractor - The Bolick Clinic of Chiropractic Wellness [Internet]. Bolickclinic.com. 2019. Available at: https://bolickclinic.com/hypothalamic-pituitary-thyroid-axis/

Turan Mİ, Çayır A, Esin İS, Demir F, Tan H. The effects of carbamazepine on thyroid functions in childhood epilepsy. Dicle Med J/Dicle Tip Dergisi. 2013 Dec 1;40(4):533-6.

Luciano Martini, GMB. Clinical Neuroendocrinology, London: Academic Press, New York, San Francisco; 1977.

Downloads

Published

2019-05-23

How to Cite

Kalsoom, U., & Ali, N. (2019). Effect of Carbamazepine on the Serum Level of Thyrotropin-Releasing Hormone. International Journal of Basic & Clinical Pharmacology, 8(6), 1349–1355. https://doi.org/10.18203/2319-2003.ijbcp20192201

Issue

Section

Original Research Articles